Ruokonen I - Search Results

1

Asymmetric dimethylarginine and hemodynamic regulation in middle-aged men.

Päivä H, Laakso J, Kähönen M, Turjanmaa V, Kööbi T, Majahalme S, Lehtimäki T, Ruokonen I, Laaksonen R. Päivä H, et al. Among authors: ruokonen i. Metabolism. 2006 Jun;55(6):771-7. doi: 10.1016/j.metabol.2006.01.014. Metabolism. 2006. PMID: 16713437

2

Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors.

Päivä H, Laakso J, Lehtimäki T, Isomustajärvi M, Ruokonen I, Laaksonen R. Päivä H, et al. Among authors: ruokonen i. J Cardiovasc Pharmacol. 2003 Feb;41(2):219-22. doi: 10.1097/00005344-200302000-00010. J Cardiovasc Pharmacol. 2003. PMID: 12548082 Clinical Trial.

3

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.

Päivä H, Lehtimäki T, Laakso J, Ruokonen I, Rantalaiho V, Wirta O, Pasternack A, Laaksonen R. Päivä H, et al. Among authors: ruokonen i. Metabolism. 2003 Mar;52(3):303-7. doi: 10.1053/meta.2003.50048. Metabolism. 2003. PMID: 12647267

4

Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemia.

Päivä H, Lehtimäki T, Laakso J, Ruokonen I, Tervonen R, Metso S, Nikkilä M, Wuolijoki E, Laaksonen R. Päivä H, et al. Among authors: ruokonen i. Metabolism. 2004 Aug;53(8):1072-5. doi: 10.1016/j.metabol.2003.12.028. Metabolism. 2004. PMID: 15281021 Clinical Trial.

5

Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidation.

Päivä H, Laakso J, Ruokonen I, Luomala M, Saarela M, Solakivi T, Metso S, Nikkilä M, Wuolijoki E, Laaksonen R, Lehtimäki T. Päivä H, et al. Among authors: ruokonen i. Clin Chim Acta. 2006 Sep;371(1-2):97-101. doi: 10.1016/j.cca.2006.02.028. Epub 2006 Mar 2. Clin Chim Acta. 2006. PMID: 16626676

6

Plasma asymmetric dimethylarginine and retinal vessel diameters in middle-aged men.

Hemminki V, Laakso J, Kähönen M, Turjanmaa V, Uusitalo H, Lehtimäki T, Ruokonen I, Laaksonen R, Huhtala H, Päivä H. Hemminki V, et al. Among authors: ruokonen i. Metabolism. 2007 Oct;56(10):1305-10. doi: 10.1016/j.metabol.2007.05.012. Metabolism. 2007. PMID: 17884437

7

Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels?

Valkonen VP, Laakso J, Päivä H, Lehtimäki T, Lakka TA, Isomustajärvi M, Ruokonen I, Salonen JT, Laaksonen R. Valkonen VP, et al. Among authors: ruokonen i. Atheroscler Suppl. 2003 Dec;4(4):19-22. doi: 10.1016/s1567-5688(03)00029-1. Atheroscler Suppl. 2003. PMID: 14664898 Clinical Trial.

8

Atomic emission method for total boron in blood during neutron-capture therapy.

Laakso J, Kulvik M, Ruokonen I, Vähätalo J, Zilliacus R, Färkkilä M, Kallio M. Laakso J, et al. Among authors: ruokonen i. Clin Chem. 2001 Oct;47(10):1796-803. Clin Chem. 2001. PMID: 11568089 Clinical Trial.

9

Inborn errors in metabolism and 4-boronophenylalanine-fructose-based boron neutron capture therapy.

Laakso J, Ruokonen I, Lapatto R, Kallio M. Laakso J, et al. Among authors: ruokonen i. Radiat Res. 2003 Nov;160(5):606-9. doi: 10.1667/rr3067. Radiat Res. 2003. PMID: 14565820

10

Clinical implementation of 4-dihydroxyborylphenylalanine synthesised by an asymmetric pathway.

Kulvik M, Vähätalo J, Buchar E, Färkkilä M, Järviluoma E, Jääskeläinen J, Kriz O, Laakso J, Rasilainen M, Ruokonen I, Kallio M. Kulvik M, et al. Among authors: ruokonen i. Eur J Pharm Sci. 2003 Feb;18(2):155-63. doi: 10.1016/s0928-0987(02)00256-7. Eur J Pharm Sci. 2003. PMID: 12594009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters